+49 3302 86 37 995

Press Releases


2019


October 2019
Microbiome: Trend in Care Supports BELANO medical AG
Current reports on the importance of the microbiome for human health confirm BELANO medical AG in its commitment to its business and product strategy. "We recognised the great significance of the microbiome years ago", emphasised CEO Dr Bernd Wegener at an event in Berlin. BELANO medical based the development of medical skincare and cosmetics care products on the results of this research. The effectiveness of both was demonstrated in several clinical trials.

September 2019
Microbiotic Medical Skincare "ibiotics med" in Long-Term Study
In an extensive user trial, BELANO medical AG has had hundreds of users test its medical skincare "ibiotics med". The invitation to the user trial was through the ibiotics Facebook page. More than 1,200 people applied. From these, 300 participants from all over Germany were selected - each of whom suffered from at least one skin condition such as atopic eczema, psoriasis, acne, or rosacea. In addition, BELANO is conducting a long-term trial for "ibiotics med", again, participants are people suffering from skin conditions such as atopic eczema or psoriasis. The trial will be launched this September and has a duration of several months.

New Findings Regarding Protection from Gastric Cancer or skin conditions
Each year, some 15,000 people in Germany are diagnosed with gastric cancer. In most cases, the disease is preceded by an infection with Helicobacter pylori, a pathogen which may also inflame the stomach lining (gastritis) and cause ulcers. To treat and prevent Helicobacter infections, doctors usually prescribe a combination of several antibiotics, though the body may develop a resistance against these. Prof. Dr. Christine Lang, Head of Scientific Board BELANO medical AG, will present effective and safe alternatives at the Allergy and Endoscopy Conference in Erlangen.

July 2019
Takeaway Skincare – New ibiotics med Sampler Set
The novel microbiotic medical skincare "ibiotics med" is now available as a convenient sampler set. Each set contains three tubes of acute care cream, intensive cream, and lotion. Users suffering from inflammatory skin diseases like dermatitis, rosacea or acne, are able to experience each product and its positive effects for about four days. Also, the handy tubes are ideal for carry-on or overnight luggage.

March 2019
Medical Skincare "ibiotics med" Now Available OTC in Pharmacies
BELANO’s novel microbiotic medical skincare "ibiotics med" is now available OTC in pharmacies across Germany and when recommended by dermatologists and medical practitioners. Sales through pharmacies are an addition to the existing online distribution which continues through pharmacy websites as well as the ibiotics-med online shop.
Sales of the medical skincare "ibiotics med" began in December 2018. It is the result of years of research in biotechnology and microbiology and differs from other skincare products in that it specifically targets the microbiome on our skin. Taking effect directly on the skin, its ingredient stimulates the natural bacteria which play a key role in a healthy skin flora.

January 2019
Additional Patent for Bio-Based Agent Against Colds
BELANO medical AG has received a patent in South Korea for its bio-based, microbiotic, and antibacterial agent "salvans". This agent is now patented in many countries, among them Germany, Austria, Switzerland, France, Spain, Italy, the United States, Japan, and China.
The microbiotic agent is based on a natural lactic acid bacterium which specifically coaggregates the pathogen Streptococcus pyogenes without harming existing healthy bacteria. This could make treatment with non-specific antiseptics or antibiotics (broad-spectrum antibiotics) unnecessary.

2018


December 2018
New Medical Skincare Using Patented Stimulans-Agent
BELANO medical AG will launch a novel microbiotic medical skincare intended for use in the complementary treatment of eczema, psoriasis, rosacea, acne, and other skin conditions. The new line "ibiotics med" includes four products – cleanser, lotion, intensive cream, and intensive care cream – and has been specifically developed for people suffering from inflammatory skin conditions and for use in treatment by dermatologists and non-medical practitioners.
This novel care product is based on the insight that in skin conditions, the skin flora – the natural diversity of healthy bacteria on the skin – is usually imbalanced. This may weaken the immune system and the skin’s resistance to disease, allowing pathogens to proliferate and triggering inflammations.

April 2018
EVONIK and BELANO cooperate in probiotic cosmetics
Evonik will market the microbiotic active ingredient "Lactobacillus Stimulans™" under the brand name "Skinolance®" worldwide and exclusively as an ingredient for cosmetic and skin care products. BELANO has developed this microbiotic active ingredient in several years of research work.
The active ingredient has the potential to establish a new generation of probiotic active cosmetics. Applications show results that could not be achieved with conventional skin care.
The active ingredient is also contained in BELANO's cosmetic care series "ibiotics™"; for irritable skin. For summer 2018, BELANO has announced "biotics™ med", a microbiotic medical skin care product series developed for supporting care of chronic inflammatory dermatoses like atopic dermatitis, psoriasis, rosacea and acne vulgaris with the active ingredient "Lactobacillus Stimulans™".

March 2018
Cosmetics trade fairs 2018: Premiere for probiotic care for irritable skin
With the skin care series "ibiotics™", BELANO is the first global supplier of a truly microbiotic skin care series in the cosmetics sector. The products cover all treatment steps from cleaning to intensive treatment and long-term care.
The offer of "ibiotics™" is aimed at professional cosmetic studios as well as dermatological specialists. End customers can obtain "ibiotics™" at the cosmetics studio, pharmacy or ibiotics online shop.

You can find ibiotics™ at the trade fairs:
- Beauty Düsseldorf 9/11 March 2018
- Beauty Forum Leipzig 21/22 April 2018
- Kosmetica Stuttgart 5/6 May 2018
- Kosmetica Frankfurt am Main 23/24 June 2018
- Kosmetica Berlin November 17-18, 2018

February 2018
Patent granted for probiotic against multi-resistant Staphylococcus aureus (MRSA)
BELANO medical AG has received a US patent for the microbial active ingredient "Dermasana™" which it has developed. The active ingredient is obtained from a lactic acid bacterium and selectively binds the pathogen Staphylococcus aureus thus allowing its elimination from infected tissues. Globally, this is one of the most common pathogens that develops resistance to multiple antibiotics (MRSA). In people with a weakened immune system, an infection with the Staphylococcus aureus can lead to death.

2017


October 2017
Probiotic Ingredient against Colds receives Patent
The probiotic ingredient "salvans" removes cold causing bacteria without attacking beneficial bacteria. This mode of action could enable new therapies without antiseptics or antibiotics. Patents granted in USA, Japan, China and other countries.

July 2017
Dr. Bernd Wegener continues as Board Member at Association of Pharmaceutical Companies (BPI)
The CEO of Belano medical AG, Dr. Bernd Wegener, is elected as Vice Chairman of the Association of Pharmaceutical Industry in Germany.

2016


October 2016
Organobalance medical AG changes name to Belano Medical AG . Business continues as before.

July 2016
Organobalance Receives U.S. Patent on Microbial Agent
- Press release

April 2016
New Skin Care Line ibiotics Uses High-tech Ingredient from Lactic Acid Bacteria to Offer Naturally Beautiful Skin
- Press release
- Product photo ibiotics
- Link Webshop www.microbiotics.de

January 2016
4th Symposium Beneficial Microbes
The Gut Flora's Influence on the Brain: Expert Conference in Berlin
- Press release


2015


September 2015
Chairwoman of Berlin Greens Briefed on Biotechnology Opportunities.
Berlin group chairwoman Ramona Pop visits ORGANOBALANCE

- Press release

June 2015
Sales Potential in the Billions for Bioeconomy in Medical and Pharmaceutical
Industries.
Article in Biotech-Report 2015 on the importance of medical biotechnology

- Press release

January 2015
Study: Combating Helicobacter Infections with Lactic Acid Bacteria
- Press release


2014


November 2014
3rd Symposium Beneficial Microbes: Microbiome and health and impressions
- Press release

April 2014
Skin microflora is important for healthy skin
- Press release


2013


November 2013
Natural bacteria to fight skin diseases and atopic dermatitis
- Press release

October 2013
Candies to fight caries
- Press release


2010


December 2010
ORGANOBALANCE Medical AG Commences Operations
"Berlin-based pharmaceutical company pursues probiotic therapies"
- Press release